Revenue Cycle / Coding / Prior Auth · Assurance Record
Waystar AltitudeAI
Waystar · Hospitals, health systems, physician practices, ambulatory · Cloud SaaS
Decision summary
- Suitable for
- CFOs, revenue cycle VPs, and CIOs at hospitals, health systems, and physician practices
- Documentary gate
- Failed
- Scenario match
- Matches this scenario — Prior-auth automation under CMS-0057-F
- Comparability
- Not yet comparable in this scenario
- Decision readiness
- HISTORICAL — Research only
- Documented evidence
- 1 of 5 evidence claims independently confirmed · confidence Moderate
- Critical unknowns
- scaled production deployment
- Last independent review
- 2026-08-27
independent reportWaystar reported Q2 2026 revenue of $319.7M (+18% YoY) and raised its FY2026 guidance; over a dozen clients committed to its new AI anomaly …2026-07-22
Exact claim. Waystar reported Q2 2026 revenue of $319.7M (+18% YoY) and raised its FY2026 guidance; over a dozen clients committed to its new AI anomaly detection solution with early adopters recovering ~$3M incremental revenue per 10,000 admissions, and Iodine cross-sell generated $6M+ in bookings.
- Source
- fiercehealthcare.com
- Type
- independent report
- Published
- 2026-07-22
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- economic_value
- Score contribution
- Feeds economic value
Independent source. Methodology and sample vary by report; read the underlying method.
Open fiercehealthcare.compress releaseWaystar reported FY2025 revenue of $1.10B (+17% YoY) with record bookings, and provided 2026 revenue guidance of ~$1.28B-$1.29B as AI-powere…2026-02-17
Exact claim. Waystar reported FY2025 revenue of $1.10B (+17% YoY) with record bookings, and provided 2026 revenue guidance of ~$1.28B-$1.29B as AI-powered innovation accelerated.
- Source
- investors.waystar.com
- Type
- press release
- Published
- 2026-02-17
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- economic_value
- Score contribution
- Feeds economic value
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open investors.waystar.compress releaseWaystar completed its acquisition of Iodine Software (closed Oct 1, 2025), adding Iodine's 1,000+ hospital clients and combining one of the …2025-10-01
Exact claim. Waystar completed its acquisition of Iodine Software (closed Oct 1, 2025), adding Iodine's 1,000+ hospital clients and combining one of the industry's largest financial datasets with one of the largest clinical datasets on a single AI platform.
- Source
- investors.waystar.com
- Type
- press release
- Published
- 2025-10-01
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- market_durability
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open investors.waystar.compress releaseWaystar launched Waystar AltitudeAI, a comprehensive set of AI capabilities including AltitudeCreate generative AI that autonomously generat…2025-01-13
Exact claim. Waystar launched Waystar AltitudeAI, a comprehensive set of AI capabilities including AltitudeCreate generative AI that autonomously generates appeal letters to recover payments tied to more than 450 million annually denied claims.
- Source
- waystar.com
- Type
- press release
- Published
- 2025-01-13
- Retrieved
- 2026-08-27
- Verification
- excerpt_matched
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- general
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open waystar.compress releaseWaystar press release (April 7, 2026): the AltitudeAI-powered Recoupment Manager reduced reconciliation time by more than 80% in early adopt…2026-04-07
Exact claim. Waystar press release (April 7, 2026): the AltitudeAI-powered Recoupment Manager reduced reconciliation time by more than 80% in early adopter deployments and, for an early adopter health system with approximately $4 billion in annual revenue, surfaced $32 million in previously hidden recoupments for review - work equivalent to approximately 27,000 hours of manual reconciliation annually or 13 full-time employees - targeting more than $40 billion in provider payments reversed annually across the industry.
- Source
- prnewswire.com
- Type
- press release
- Published
- 2026-04-07
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- economic_value
- Score contribution
- Feeds economic value
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open prnewswire.comVerified provider experience is not yet publishable. Fewer than five independent provider organizations have contributed eligible reviews. Reviewer mode is off. Experience never changes documentary scoring, freshness, or rank.
Buyer lenses — evidence-backed bands (not a 0–100 rank)
Deployment, integration, data handling
- Integration maturity
- announced — Announced or documented integration; marketplace listing not confirmed.
- EHR path
- Epic, MEDITECH, Oracle Health (Cerner), eClinicalWorks, NextGen, Veradigm (Allscripts)
- FHIR / API
- UNKNOWN
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- SSO
- UNKNOWN
Why unknown
Why. Single-sign-on support is not documented in vendor or marketplace materials on file.
What would close it. Vendor security documentation or marketplace listing mentioning SSO/SAML/OIDC.
- PHI / BAA
- PHI processed in-scope; HIPAA-compliant (HITRUST CSF and SOC 2 Type 2 certified) · BAA available
- Security attestations
- HITRUST CSF, SOC 2 Type 2, PCI DSS
- FDA status
- UNKNOWN
Why unknown
Why. No FDA listing found for this product's functions in the tracked category.
What would close it. An FDA 510(k)/De Novo listing, or a clear statement that no regulated function is claimed.
- Pricing
- Not publicly listed
Technical provenance
snap_8a8a4c9bb810aee3 · 2026-08-27T04:05Z · build 6a9fe1b
Forecast calibration is not in the public snapshot — shown as UNKNOWN rather than read from SQLite.
Known limitations
- Deployment traction is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- Market durability is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.